Actinogen Medical Ltd 3AC-FF:Frankfurt Stock Exchange

RT Quote | Exchange | EUR
Last | 8:02 AM CEST
0.034quote price arrow down-0.0005 (-1.45%)
52 week range
0.03 - 0.12
Loading...
  • Open0.034
  • Day High0.034
  • Day Low0.034
  • Prev Close0.058
  • 52 Week High0.12
  • 52 Week High Date11/12/21
  • 52 Week Low0.03
  • 52 Week Low Date05/12/22

Key Stats

  • Market Cap97.56M
  • Shares Out1,774.85M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-61.8

KEY STATS

  • Open0.034
  • Day High0.034
  • Day Low0.034
  • Prev Close0.058
  • 52 Week High0.12
  • 52 Week High Date11/12/21
  • 52 Week Low0.03
  • 52 Week Low Date05/12/22
  • Market Cap97.56M
  • Shares Out1,774.85M
  • 10 Day Average Volume-
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-61.8

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Actinogen Medical Ltd

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Actinogen Medical Limited is an Australia-based biotechnology company. The Company is focused on developing therapy for neurological diseases associated with dysregulated brain cortisol. Its lead compound, Xanamem, is a therapy for Alzheimer's disease, fragile x syndrome, major depressive disorder and other neurological diseases. It is designed to block the production of cortisol the stress hormone in the brain. Xanamem is an inhibitor of the 11β-HSD1 enzyme that achieves...
Geoffrey Brooke M.D.
Non-Executive Chairman of the Board
Steven Gourlay
Chief Executive Officer, Managing Director
Jeff Carter
Chief Financial Officer
Address
Select House
SE 901 L 9, 109 Pitt Street
Sydney, NSW
2000
Australia